Show simple item record

Inhibition of angiogenesis by interleukin-4 gene therapy in rat adjuvant-induced arthritis

dc.contributor.authorHaas, Christian S.en_US
dc.contributor.authorAmin, Mohammed Asifen_US
dc.contributor.authorAllen, Brittany B.en_US
dc.contributor.authorRuth, Jeffrey H.en_US
dc.contributor.authorHaines, G. Kenneth IIIen_US
dc.contributor.authorWoods, James M.en_US
dc.contributor.authorKoch, Alisa E.en_US
dc.date.accessioned2007-09-18T19:23:44Z
dc.date.available2007-09-18T19:23:44Z
dc.date.issued2006-08en_US
dc.identifier.citationHaas, Christian S.; Amin, M. Asif; Allen, Brittany B.; Ruth, Jeffrey H.; Haines, G. Kenneth; Woods, James M.; Koch, Alisa E. (2006). "Inhibition of angiogenesis by interleukin-4 gene therapy in rat adjuvant-induced arthritis." Arthritis & Rheumatism 54(8): 2402-2414. <http://hdl.handle.net/2027.42/55808>en_US
dc.identifier.issn0004-3591en_US
dc.identifier.issn1529-0131en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/55808
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=16869003&dopt=citationen_US
dc.description.abstractObjective Interleukin-4 (IL-4) can modulate neovascularization. In this study, we used a gene therapy approach to investigate the role of IL-4 in angiogenesis in rat adjuvant-induced arthritis (AIA), a model for rheumatoid arthritis. Methods Rats received an adenovirus producing IL-4 (AxCAIL-4), a control virus without insert, or control vehicle (phosphate buffered saline) intraarticularly before arthritis onset. At peak onset of arthritis, rats were killed. Vascularization was determined in the synovial tissue, and correlations with inflammation were assessed. Ankle homogenates were used in angiogenesis assays in vitro and in vivo, and protein levels of cytokines and growth factors were assessed by enzyme-linked immunosorbent assay. Synovial tissue expression of Αv integrins was determined by immunohistochemistry. Results IL-4 induced a reduction in synovial tissue vessel density, which was paralleled by a decrease in inflammation. AxCAIL-4 joint homogenates significantly ( P < 0.05) inhibited both endothelial cell (EC) migration and tube formation in vitro. Similarly, AxCAIL-4 inhibited capillary sprouting in the rat aortic ring assay, and vessel growth in the in vivo Matrigel plug assay. The angiostatic effect occurred despite high levels of vascular endothelial growth factor (VEGF), and was associated with down-regulation of the proangiogenic cytokines IL-18, CXCL16, and CXCL5 and up-regulation of the angiogenesis inhibitor endostatin. Of interest, AxCAIL-4 also resulted in decreased EC expression of the Αv and Β3 integrin chains. Conclusion In rat AIA, IL-4 reduces synovial tissue vascularization via angiostatic effects, mediates inhibition of angiogenesis via an association with altered pro- and antiangiogenic cytokines, and may inhibit VEGF-mediated angiogenesis and exert its angiostatic role in part via ΑvΒ3 integrin. This knowledge of the specific angiostatic effects of IL-4 may help optimize target-oriented treatment of inflammatory arthritis.en_US
dc.format.extent814212 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.publisherWiley Subscription Services, Inc., A Wiley Companyen_US
dc.subject.otherLife and Medical Sciencesen_US
dc.titleInhibition of angiogenesis by interleukin-4 gene therapy in rat adjuvant-induced arthritisen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelGeriatricsen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumUniversity of Michigan Medical School, Ann Arboren_US
dc.contributor.affiliationumUniversity of Michigan Medical School, Ann Arboren_US
dc.contributor.affiliationumUniversity of Michigan Medical School, Ann Arboren_US
dc.contributor.affiliationumUniversity of Michigan Medical School, Ann Arboren_US
dc.contributor.affiliationumDepartment of Veterans Affairs Medical Center, and University of Michigan Medical School, Ann Arbor ; University of Michigan Medical School, Department of Medicine, Division of Rheumatology, 1150 West Medical Center Drive, Ann Arbor, MI 48109-0680en_US
dc.contributor.affiliationotherNorthwestern University Feinberg Medical School, Chicago, Illinoisen_US
dc.contributor.affiliationotherMidwestern University, Downers Grove, Illinoisen_US
dc.identifier.pmid16869003en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/55808/1/22034_ftp.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1002/art.22034en_US
dc.identifier.sourceArthritis & Rheumatismen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.